Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.7 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.12 | 0.7 |
mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.7 |